Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.

Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, Calabretta B.

Blood. 1995 Jul 15;86(2):726-36.

PMID:
7606002
[PubMed - indexed for MEDLINE]
Free Article
2.

Chronic myelogenous leukemia: molecular and cellular aspects.

Pasternak G, Hochhaus A, Schultheis B, Hehlmann R.

J Cancer Res Clin Oncol. 1998;124(12):643-60. Review.

PMID:
9879825
[PubMed - indexed for MEDLINE]
3.

Molecular biology of chronic myeloid leukemia.

Maru Y.

Int J Hematol. 2001 Apr;73(3):308-22. Review.

PMID:
11345196
[PubMed - indexed for MEDLINE]
4.

Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.

Warmuth M, Danhauser-Riedl S, Hallek M.

Ann Hematol. 1999 Feb;78(2):49-64. Review.

PMID:
10089019
[PubMed - indexed for MEDLINE]
5.

Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.

Sattler M, Salgia R.

Cytokine Growth Factor Rev. 1997 Mar;8(1):63-79. Review.

PMID:
9174663
[PubMed - indexed for MEDLINE]
6.

BCR/ABL regulation of PI-3 kinase activity.

Calabretta B, Skorski T.

Leuk Lymphoma. 1996 Nov;23(5-6):473-6. Review.

PMID:
9031078
[PubMed - indexed for MEDLINE]
7.

Recent advances in molecular biology of chronic myeloid leukaemia: is the pathogenetic puzzle approaching solution?

Goldman JM.

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:129-30. Review.

PMID:
2496882
[PubMed - indexed for MEDLINE]
8.

Stem cell factor and chronic myeloid leukemia CD34+ cells.

Moore S, McDiarmid LA, Hughes TP.

Leuk Lymphoma. 2000 Jul;38(3-4):211-20. Review.

PMID:
10830729
[PubMed - indexed for MEDLINE]
9.

The molecular biology of chronic myeloid leukaemia.

Melo JV.

Leukemia. 1996 May;10(5):751-6. Review.

PMID:
8656667
[PubMed - indexed for MEDLINE]
10.
11.

New understanding of the pathogenesis of CML: a prototype of early neoplasia.

Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N.

Leukemia. 1997 Sep;11(9):1404-28. Review.

PMID:
9305592
[PubMed - indexed for MEDLINE]
12.

Inhibition of P210 expression in chronic myeloid leukaemia: oligonucleotides and/or transduced antisense sequences.

Lewalle P, Martiat P.

Leuk Lymphoma. 1993;11 Suppl 1:139-43. Review.

PMID:
8251887
[PubMed - indexed for MEDLINE]
13.

Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors.

Ichim CV.

Stem Cells Transl Med. 2014 Apr;3(4):405-15. doi: 10.5966/sctm.2012-0159. Epub 2014 Mar 5. Review.

PMID:
24598782
[PubMed - indexed for MEDLINE]
14.

CML: mechanisms of disease initiation and progression.

Wetzler M, Talpaz M, Estrov Z, Kurzrock R.

Leuk Lymphoma. 1993;11 Suppl 1:47-50. Review.

PMID:
8251916
[PubMed - indexed for MEDLINE]
15.

Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment.

Clarkson B, Strife A.

Leukemia. 1993 Nov;7(11):1683-721. Review.

PMID:
8231240
[PubMed - indexed for MEDLINE]
16.

BCR/ABL signal transduction.

Tauchi T, Broxmeyer HE.

Int J Hematol. 1995 Apr;61(3):105-12. Review.

PMID:
7599321
[PubMed - indexed for MEDLINE]
17.

A coiled-coil tetramerization domain of BCR-ABL is essential for the interactions of SH2-containing signal transduction molecules.

Tauchi T, Miyazawa K, Ohyashiki K, Toyama K.

Hum Cell. 1996 Dec;9(4):333-6. Review.

PMID:
9183666
[PubMed - indexed for MEDLINE]
18.

Cell biology of CML cells.

Gordon MY, Dazzi F, Marley SB, Lewis JL, Nguyen D, Grand FH, Davidson RJ, Goldman JM.

Leukemia. 1999 Apr;13 Suppl 1:S65-71. Review.

PMID:
10232368
[PubMed - indexed for MEDLINE]
19.

Pleiotropic p27(Kip1), BCR-ABL and leukemic stem cell: the trio in concert.

Sengupta A, Banerjee S.

Leukemia. 2007 Dec;21(12):2559-61. Epub 2007 Jul 5. Review. No abstract available.

PMID:
17611557
[PubMed - indexed for MEDLINE]
20.

The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia.

Fernandes RS, Gorman AM, McGahon A, Lawlor M, McCann S, Cotter TG.

Leukemia. 1996 Jun;10 Suppl 2:s17-21. Review.

PMID:
8649049
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk